版本:
中国

BRIEF-Sierra Oncology granted U.S., EU patents for CHK1 inhibitor SRA737

May 30 Sierra Oncology Inc

* Sierra Oncology granted U.S. and EU patents for CHK1 inhibitor SRA737 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐